Princeton, New Jersey, United States The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Princeton.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Anacor Pharmaceutical, Vaxart, MicroCHIPS. Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Care Capital, startups are often financed by Rho Ventures, MedImmune Ventures, Domain Associates. The meaningful sponsors for the fund in investment in the same round are MedImmune Ventures, HealthCare Ventures, Domain Associates. In the next rounds fund is usually obtained by Rho Ventures, Pitango Venture Capital, MedImmune Ventures.
The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Care Capital the average startup value is 10-50 millions dollars. The important activity for fund was in 2010. The increased amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Care Capital performs on 9 percentage points more the average number of lead investments. Considering the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations.
The current fund was established by David R. Ramsay, Jan Leschly, John Parker. Besides them, we counted 3 critical employees of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Abbey Road Red | England, London, United Kingdom |
| ASE Global Group | New York, New York, United States |
| DeSimone Group Investments | Cherry Hill, New Jersey, United States |
| Fond fondov | District of Zvolen, Region of Banská Bystrica, Slovakia |
| G1 Ventures | England, London, United Kingdom |
| Groupe Casino | France, Rhone-Alpes, Saint Etienne |
| HTG | Japan, Osaka, Osaka Prefecture |
| ITI Energy | - |
| Kurt Bilafer's Syndicate | Kirkland, United States, Washington |
| Long Focus Capital | - |
| Lucent Venture Partners | California, Palo Alto, United States |
| Muniu Touzi | China, Guangdong, Shenzhen |
| Societe Innovatech du Grand Montreal | Canada, Montréal, Quebec |
| Strandview Capital | California, El Segundo, United States |
| SVB Leerink | Boston, Massachusetts, United States |
| Tech Invest Com | Ar Riyad, Riyadh, Saudi Arabia |
| Tongbanjie | China, Hangzhou, Zhejiang |
| Walmart | Arkansas, Bentonville, United States |
| Wosheng Cci Capital | China, Guangxi, Jiangsu |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CoLucid Pharmaceuticals | $37M | 13 Jan 2015 | Durham, North Carolina, United States | ||
Agile Therapeutics | $40M | 19 Jul 2012 | New Jersey, United States | ||
Elevation Pharmaceuticals | $30M | 04 Jan 2012 | San Diego, California, United States | ||
Elevation Pharmaceuticals | $17M | 26 Sep 2011 | San Diego, California, United States | ||
Agile Therapeutics | $45M | 14 Jun 2010 | New Jersey, United States | ||
NormOxys | $17M | 24 May 2010 | Massachusetts, United States | ||
| $9M | 04 Mar 2010 | San Francisco, California, United States | |||
Elevation Pharmaceuticals | $30M | 21 Jan 2010 | United States, San Diego | ||
CoLucid Pharmaceuticals | $25M | 01 Jul 2008 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CoLucid Pharmaceuticals | $37M | 13 Jan 2015 | Durham, North Carolina, United States | ||
Agile Therapeutics | $40M | 19 Jul 2012 | New Jersey, United States | ||
Elevation Pharmaceuticals | $30M | 04 Jan 2012 | San Diego, California, United States | ||
Elevation Pharmaceuticals | $17M | 26 Sep 2011 | San Diego, California, United States | ||
Agile Therapeutics | $45M | 14 Jun 2010 | New Jersey, United States | ||
NormOxys | $17M | 24 May 2010 | Massachusetts, United States | ||
| $9M | 04 Mar 2010 | San Francisco, California, United States | |||
Elevation Pharmaceuticals | $30M | 21 Jan 2010 | United States, San Diego | ||
CoLucid Pharmaceuticals | $25M | 01 Jul 2008 | Durham, North Carolina, United States |
